fluoxetine has been researched along with Acute Bacterial Prostatitis in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine appears to be a safe and effective treatment in improving symptoms in, and the quality of life of, men with difficult CP/CPPS." | 6.76 | Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. ( Chen, J; Jiang, H; Wang, P; Wang, S; Xia, D, 2011) |
| "Fluoxetine appears to be a safe and effective treatment in improving symptoms in, and the quality of life of, men with difficult CP/CPPS." | 2.76 | Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. ( Chen, J; Jiang, H; Wang, P; Wang, S; Xia, D, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, D | 1 |
| Wang, P | 1 |
| Chen, J | 1 |
| Wang, S | 1 |
| Jiang, H | 1 |
1 trial available for fluoxetine and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Fluoxetine; Humans; Male; Middle A | 2011 |